L’Oréal recalling acne creams sold at Walmart, Target, and Walgreens due to ‘cancer-causing chemical’
Makeup company L’Oréal has recalled popular brand La Roche-Posay’s acne cream because it may contain benzene, a cancer-causing chemical, according to New York Post. Effaclar Duo Dual-Action Acne Treatment contains benzoyl peroxide, which could have the known carcinogen, according to Valisure, an independent testing lab in Connecticut.
Beauty care company issues recall for facial treatment due to cancer-causing chemical
One of the biggest beauty brands issued a voluntary recall for a facial treatment due to concerns that it may contain a cancer-causing chemical.
L'Oréal SA recalls Effaclar Duo in the US over fears acne treatment may contain cancer-causing chemical
L’Oréal SA has voluntarily recalled all lots of its Effaclar Duo in the US over concerns that it may contain cancer-causing chemicals. The acne treatment is produced under the beauty company’s La Roche-Posay skin care brand and contains benzoyl peroxide (BPO).
Popular makeup brand recalls acne treatment for possible cancer-causing ingredient
Makeup company L’Oréal S.A. has issued a recall on its popular acne cream Effaclar Duo due to concern that benzene, a known carcinogen, is in the product. Last year, independent Connecticut testing lab Valisure,
Hugely popular face cream is urgently recalled in US over contamination with chemical linked to cancer
A HUGELY popular beauty item has been urgently recalled over fears they could contain cancer-causing chemicals. L’Oréal has slapped a ‘do not use’ alert on its La Roche Posay
L’Oreal Recalls Popular La Roche-Posay Acne Treatment Over Cancer-Causing Chemical
Posay’s Effaclar Duo acne treatment due to concerns over benzene contamination, a known carcinogen.Benzoyl peroxide, a key ingredient in Effaclar Duo, can degrade into benzene under certain conditions,
Acne product from popular skin care brand recalled due to potential cancer-causing chemical
The chemical that caused the recall is found in gasoline and tobacco; large amounts of the chemical can cause leukemia.
Cancer-causing chemical leads popular company to recall skin product
The recall comes in the wake of concerns over contamination of benzene, news outlet reported. A spokesperson for La Roche-Posay wrote in a statement to cleveland.com and The Plain Dealer that product safety is the company’s highest priority.
L’Oréal Act for Dermatology Aims to Democratize Skin Health Access
The 20 million euro, five-year program is to help support the 2.1 billion people worldwide living with skin disease.
Meet world's five richest women: From L'Oréal to Amazon, which companies are they associated with?
They own billions of dollars but are also known for making strides in the fields of business and philanthropy. They are ...
Beauty Packaging18h
L’Oréal Reinforces Leadership and Commitment to Cosmetic Safety
Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our ...
Cosmetics Business1d
L’Oréal’s dermatology arm launches €20 million skin health programme
L’Oréal Groupe has launched L’Oréal Act for Dermatology, a five-year skin health programme, under its Dermatological Beauty ...
CNA3h
CNA938 Rewind - Empowering SG Women in Science with the L'Oréal Foundation and UNESCO
In ‘Made in SG’, Melanie Oliveiro speaks with two local scientists who were celebrated at the L’Oréal-UNESCO For Women in Science programme. Assistant Professor Iris Yu from NUS will discuss how she p ...
The Weekly Closeout: Trade groups sound the alarm on tariffs, L’Oréal sells Carol’s Daughter
RILA, NRF and AAFA all raised red flags about President Trump’s trade policies, while the beauty conglomerate sold the brand ...
Asian News International on MSN3d
L'Oréal Paris Hyaluron Pure sets Guinness World Record with 'Free Your Hair' Campaign
L'Oréal Paris, world's No.1 beauty brand, made history with a Guinness World Record for the 'Most People Untying Their Hair ...
Inside L'Oréal's Biggest Bet Yet on Innovation
The number of potential consumers in the U.S. is expected to increase by 12 million over the next five years, Nicolas ...